Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Osteoporos Int. 2014 Sep 16;26(3):1035–1044. doi: 10.1007/s00198-014-2874-3

Figure 1. Change in bone turnover markers, vitamin D, and parathyroid hormone over two years, by treatment group.

Figure 1

A. Serum levels of C-terminal cross-linking telopeptide of type-1 collagen (CTX) B. Serum levels of procollagen type 1 N-terminal propeptide (P1NP) C. Serum levels of 25-hydroxy vitamin D (25OHD)D. Serum levels of intact parathyroid hormone (iPTH). AZT+NVP = zidovudine+nevirapine; TDF+LPVr = tenofovir+lopinavir/ritonavir; * p≤0.01; ** p=0.05.